A subject this map covers
Myelin inhibitor blockade
Part of: Axon growth and regeneration
This map follows this subject as an approach
What belongs here
Lifting the inhibitory myelin signals that stop a fibre growing.
What does not belong here, however close it looks
Remyelination to restore conduction is a different aim — the oligodendrocyte-progenitor concept.
What has been looked at
Counted from what the sources catalogue, not from reading the work. It says how much exists and over what span of years — never what any of it found.
- Registered or indexed as work in people: 124 records · 1983–2026
- Indexed as work in animals: 268 records · 1977–2025
- Indexed as laboratory work: 19 records · 1986–2018
- The source has not said who or what was studied: 58 records · 2002–2026
- Nobody has yet checked any of this against its original for this map, so none of it is on the checked shelf.
Checked
Records a person has read against the original and published into this map. These carry measurements, evidence states and a place on the ladder.
Nobody has checked a record on this subject yet.
Checking is done by a person, one record at a time, and this subject has not reached the queue yet. The shelf below is what the sources hold in the meantime; it has not been read by anybody.
Found in the scientific sources, not yet checked
Titles and identifiers as the sources publish them. Nobody here has read these papers, and nothing on this shelf is a result, a recommendation or evidence that anything works. Each line opens the original.
469 records
This grouping is the source's own cataloguing, not a reading of the paper. It says where a record was filed, not what it found.
The source has not said who or what was studied
- Nogo-A Is a Potential Prognostic Marker for Spinal Cord Injury — Crossref · 2022 · journal-article
- miR-182-5p Regulates Nogo-A Expression and Promotes Neurite Outgrowth of Hippocampal Neurons In Vitro. — PubMed · 2022 · Journal Article
- Anti-repulsive guidance molecule: An antibody treatment in spinal cord injury — Crossref · 2022 · book-chapter
- Regulation of neuronal repair and regeneration through inhibition of oligodendrocyte myelin glycoprotein (OMgp). — PubMed · 2022 · Journal Article
- Cutaneous Inputs to Dorsal Column Nuclei in Adult Macaque Monkeys Subjected to Unilateral Lesion of the Primary Motor Cortex or of the Cervical Spinal Cord and Treatments Promoting Axonal Growth. — PubMed · 2020 · Journal Article
- Lumbosacral sprouting of bladder afferents after thoracic spinal cord injury reflects changes in levels of Nogo-A — Crossref · 2020 · journal-article
- Faculty Opinions recommendation of First-in-Man Intrathecal Application of Neurite Growth-Promoting Anti-Nogo-A Antibodies in Acute Spinal Cord Injury. — Crossref · 2020 · dataset
- Recovery after spinal cord injury is enhanced by anti-Nogo-A antibody therapy — from animal models to clinical trials — Crossref · 2020 · journal-article
- Evaluating the effectiveness of anti-Nogo treatment in spinal cord injuries — Crossref · 2020 · journal-article
- Orphan designation: Recombinant human monoclonal antibody to human Nogo-A protein of the IgG4/kappa class (atinumab), Treatment of spinal cord injury — Crossref · 2019 · journal-article
- Corticotectal Projections From the Premotor or Primary Motor Cortex After Cortical Lesion or Parkinsonian Symptoms in Adult Macaque Monkeys: A Pilot Tracing Study. — PubMed · 2019 · Journal Article
- NISCI - Nogo Inhibition in Spinal Cord Injury — Crossref · 2019 · journal-article
- Anti-Nogo-A antibodies: Promising treatment for neurogenic lower urinary tract dysfunction after spinal cord injury — Crossref · 2019 · journal-article
- Anti-Nogo-A antibodies: A causal treatment for neurogenic lower urinary tract dysfunction due to spinal cord injury? — Crossref · 2018 · journal-article
- Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury. — PubMed · 2017 · Journal Article
- Sequential therapy of anti-Nogo-A antibody treatment and treadmill training leads to cumulative improvements after spinal cord injury in rats — Crossref · 2017 · journal-article
- Faculty Opinions recommendation of Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. — Crossref · 2016 · dataset
- Antibody-mediated inhibition of Nogo-A signaling promotes neurite growth in PC-12 cells. — PubMed · 2016 · Journal Article
- Blocking the Nogo-A Signaling Pathway to Promote Regeneration and Plasticity After Spinal Cord Injury and Stroke — Crossref · 2016 · book-chapter
- Nogo-A expression dynamically varies after spinal cord injury — Crossref · 2015 · journal-article
- Strategies for myelin regeneration: lessons learned from development. — PubMed · 2014 · Journal Article
- Reticulon 4 (RTN4; NOGO-A; NOGO; NOGO-B) — Crossref · 2014 · journal-article
- Combination of Chondroitinase ABC, Glial Cell Line–Derived Neurotrophic Factor and Nogo A Antibody Delayed-Release Microspheres Promotes the Functional Recovery of Spinal Cord Injury — Crossref · 2013 · journal-article
- Small Nogo-66-binding peptide promotes neurite outgrowth through RhoA inhibition after spinal cord injury — Crossref · 2013 · journal-article
- Blocking Nogo Receptor 1 Promotes Functional Regeneration after Spinal Cord Injury — Crossref · 2013 · journal-article
- In vitro sustained release of bioactive anti-NogoA, a molecule in clinical development for treatment of spinal cord injury. — PubMed · 2012 · Journal Article
- Delayed Anti-Nogo-A Antibody Application after Spinal Cord Injury Shows Progressive Loss of Responsiveness — Crossref · 2012 · journal-article
- Reticulon 4 (RTN4; NOGO-A; NOGO; NOGO-B) — Crossref · 2011 · journal-article
- P133. The role of Nogo on the guidance of commissural axons in the mouse spinal cord — Crossref · 2010 · journal-article
- Effect of Combined Treatment with Methylprednisolone and Nogo-A Monoclonal Antibody after Rat Spinal Cord Injury — Crossref · 2010 · journal-article
- Cortical Changes Following Spinal Cord Injury with Emphasis on the Nogo Signaling System — Crossref · 2009 · journal-article
- Differential effects of anti-Nogo-A antibody treatment and treadmill training in rats with incomplete spinal cord injury — Crossref · 2009 · journal-article
- A quantitative ELISA for bioactive anti-Nogo-A, a promising regenerative molecule for spinal cord injury repair — Crossref · 2009 · journal-article
- Nogo-Neutralizing Antibody IN-1 — Crossref · 2009 · book-chapter
- Lamina‐specific restoration of serotonergic projections after Nogo‐A antibody treatment of spinal cord injury in rats — Crossref · 2008 · journal-article
- Rearrangement of cortical sensory maps after spinal cord injury : Functional MRI responses linked to Nogo receptor(Extended abstract) — Crossref · 2008 · journal-article
- STRATEGIES TO INHIBIT SIGNALING THROUGH NOGO RECEPTOR 1 FOR SPINAL CORD INJURY AND STROKE — Crossref · 2008 · book-chapter
- Antibodies neutralizing Nogo-A increase pan-cadherin expression and motor recovery following spinal cord injury in rats — Crossref · 2007 · journal-article
- Cortical sensory map rearrangement after spinal cord injury: fMRI responses linked to Nogo signalling — Crossref · 2007 · journal-article
- Anti‐Nogo‐A antibody treatment enhances sprouting of corticospinal axons rostral to a unilateral cervical spinal cord lesion in adult macaque monkey — Crossref · 2007 · journal-article
- Nogo in the Injured Spinal Cord — Crossref · 2006 · journal-article
- Regenerating corticospinal fibers in the Marmoset (<i>Callitrix jacchus</i>) after spinal cord lesion and treatment with the anti‐Nogo‐A antibody IN‐1 — Crossref · 2004 · journal-article
- Nogo-66 Receptor Prevents Raphespinal and Rubrospinal Axon Regeneration and Limits Functional Recovery from Spinal Cord Injury — Crossref · 2004 · journal-article
- Structural characterization of the human Nogo‐A functional domains — Crossref · 2004 · journal-article
- Myelin-associated inhibitors of axon regeneration. — PubMed · 2003 · Journal Article
- Olfactory ensheathing cell phenotype following implantation in the lesioned spinal cord. — PubMed · 2003 · Journal Article
- Faculty Opinions recommendation of Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. — Crossref · 2003 · dataset
- Delayed Systemic Nogo-66 Receptor Antagonist Promotes Recovery from Spinal Cord Injury — Crossref · 2003 · journal-article
- Chapter 25 Nogo and the Nogo-66 receptor — Crossref · 2002 · book-chapter
Where this was looked for, and when
The exact question each source was asked, the day it was asked, and what came back. A zero on this page is only honest if these are on it.
| ClinicalTrials.gov | asked, and it has nothing | asked on 2026-10-05 | the source found 0 · this programme has 1 · still to fetch 0 | aim: every record matching this question |
|---|---|---|---|---|
| Crossref | asked, and it answered | asked on 2026-09-16 | the source found 1641516 · this programme has 49 | aim: a sample of the most relevant records. This source ranks a bag of words, so its own total is the size of the corpus that shares some of them, never a set still owed. |
| PubMed | asked, and it has nothing | asked on 2026-10-12 | the source found 0 · this programme has 452 · still to fetch 0 | aim: every record matching this question |
The question asked
- ClinicalTrials.gov
("anti-Nogo" OR "Nogo-A antibody" OR "myelin associated inhibitor") - Crossref
spinal cord injury anti-Nogo Nogo-A antibody - PubMed
("Spinal Cord Injuries"[MeSH Terms] OR "spinal cord injury"[Title/Abstract] OR "spinal cord injuries"[Title/Abstract] OR "spinal cord trauma"[Title/Abstract]) AND ("Myelin Proteins"[MeSH Terms] OR "Nogo Proteins"[MeSH Terms] OR "anti-Nogo"[Title/Abstract] OR "Nogo-A antibody"[Title/Abstract] OR "myelin associated inhibitor"[Title/Abstract])